MNA
HALO icon

Manning & Napier Advisors’s Halozyme HALO Stock Holding History

Manning & Napier Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47K Buy
+32
New +$2.18K ﹤0.01% 705

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Manning & Napier Advisors's HALO Position: Q2 2026 in Review

Manning & Napier Advisors opened a new position in Halozyme (HALO) in Q2 2026: 32 shares worth $2.47K. The stake represents ﹤0.01% of the portfolio and ranks #705 among its holdings.

668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Manning & Napier Advisors held 32 shares of Halozyme worth $2.47K as of Q2 2026.
  • Halozyme was a new Manning & Napier Advisors position in Q2 2026.
  • Halozyme made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #705 holding.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.